Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Biotin-16-UTP: Precision Tools for lncRNA-Protein Interactio
2026-06-04
Discover how Biotin-16-UTP enables high-precision mapping of long non-coding RNA (lncRNA) and protein interactions. This in-depth article explores its unique mechanistic value in advanced RNA detection, especially within cancer research.
-
gamma-Glu-Cys (γ-Glu-Cys): Technical Use in Glutathione Rese
2026-06-04
gamma-Glu-Cys (γ-Glu-Cys) is an essential substrate for researchers investigating glutathione metabolism and peptide synthesis workflows. It provides a high-purity, workflow-compatible intermediate, enabling reproducible enzyme assays and plant stress adaptation studies. It is not designed for use in clinical, diagnostic, or in vivo therapeutic applications.
-
Mechanistic Strategies for Robust cDNA Synthesis in qPCR Wor
2026-06-03
This thought-leadership article explores the mechanistic and strategic considerations essential for translational researchers tackling low-abundance or structurally complex RNA templates in quantitative PCR (qPCR) workflows. By synthesizing insights from recent retrovirology advances and leveraging the capabilities of HyperScript™ Reverse Transcriptase, we provide actionable guidance and a forward-looking perspective on precision cDNA synthesis.
-
SP600125 in Translational Control: Beyond JNK Inhibition
2026-06-03
Explore how SP600125, a selective JNK inhibitor, uniquely empowers researchers to dissect translational regulation, apoptosis, and inflammation. This article offers advanced scientific insight and practical protocols, distinguishing its approach from existing reviews.
-
Thioguanine: Epigenetic Precision for Translational Oncology
2026-06-02
This thought-leadership article explores the mechanistic depth and translational utility of thioguanine (6-thioguanine) in oncology and antiviral research, focusing on its dual inhibition of DNMT1 and HGPRT and its implications for acute lymphoblastic leukemia (ALL) and beyond. Drawing from recent epigenetic studies and advanced protocol insights, it provides actionable guidance for translational researchers and differentiates APExBIO’s thioguanine offering within a competitive landscape.
-
PSPro Enables Single-Cell-Type Spatial Proteome Profiling in
2026-06-02
Mao et al. introduce PSPro, a proximity labeling-based workflow that achieves all-at-once spatial proteome profiling with single-cell-type resolution in complex tissue slices. This approach reveals spatial heterogeneity among cell subsets and advances the precision of spatial proteomics for biomedical research.
-
(S)-Mephenytoin in CYP2C19 Metabolism: Insights & Protocols
2026-06-01
(S)-Mephenytoin is an essential CYP2C19 substrate for advanced cytochrome P450 metabolism studies. Explore novel experimental strategies and translational insights that set this guide apart from existing resources.
-
Frizzled5 Links Cholesterol Metabolism to Wnt Signaling in P
2026-06-01
This study reveals that Frizzled5 (Fzd5) uniquely senses cholesterol via its extracellular linker, promoting receptor palmitoylation and plasma membrane trafficking. Such cholesterol-dependent maturation of Fzd5 drives Wnt/β-catenin signaling and pancreatic cancer growth, suggesting new therapeutic strategies targeting cholesterol-Fzd5 interactions.
-
AICAR Phosphate (Acadesine): Advanced Workflows for Apoptosi
2026-05-31
AICAR phosphate (Acadesine) unlocks precise AMPK-driven apoptosis and mitophagy, enabling selective targeting of B-CLL cells and inflammation pathways. Learn best-practice protocols, troubleshooting, and how the latest mechanistic advances translate to superior experimental reproducibility.
-
Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat
2026-05-30
The Cy5 TSA Fluorescence System Kit elevates sensitivity in IHC, ICC, and FISH, enabling robust detection of low-abundance targets with rapid, HRP-catalyzed tyramide deposition. This article unpacks advanced workflows, optimization insights, and troubleshooting strategies, tying mechanistic innovation to practical outcomes for spatial and single-cell applications.
-
Hippo Signaling Modules Orchestrate Hepatobiliary Cell Fate
2026-05-29
The referenced study uncovers how two distinct modules within the Hippo signaling pathway, HPO1 and HPO2, regulate the maturation and lineage fate of hepatocytes and cholangiocytes during liver development. These findings clarify the spatiotemporal mechanisms underlying liver cell plasticity and have implications for regenerative medicine and liver disease research.
-
Protease Inhibitor Cocktail (100X): Enabling Precision in Ad
2026-05-29
Explore how the Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) safeguards protein integrity for advanced applications. This article reveals deeper scientific insights and protocol strategies for reliable protein degradation prevention.
-
Targeting BCL-XL in Glioblastoma: Insights from BH3-Mimetic
2026-05-28
The referenced Cell Death & Differentiation study demonstrates that glioblastoma (GBM) exhibits heightened susceptibility to apoptosis via selective inhibition of anti-apoptotic BCL-2 family proteins, particularly BCL-XL and MCL-1. By leveraging BH3-mimetic compounds, the research provides a mechanistic rationale for targeting these proteins in GBM, revealing therapeutic vulnerabilities that could be exploited in preclinical and translational cancer research.
-
A-1155463: Precision BCL-XL Inhibition for Cancer Resistance
2026-05-28
Discover how the selective BCL-XL inhibitor A-1155463 enables precise apoptosis induction in drug-resistant cancer models. This article reveals new scientific perspectives and advanced protocols for translational oncology research.
-
Technical Guidance for Biotin-16-UTP: RNA Labeling Protocols
2026-05-27
Biotin-16-UTP is a biotin-labeled uridine triphosphate designed for precise RNA labeling during in vitro transcription. It addresses challenges in RNA detection, purification, and interaction studies where high specificity and downstream compatibility are essential. This reagent should not be used in diagnostic or clinical workflows, and its use is limited to research applications requiring biotinylated RNA.